These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14851666)

  • 1. [Experimental induction of fibrinolysis by injection of fibrinolytic enzymes].
    von KAULLA KN
    Klin Wochenschr; 1951 Jun; 29(23-24):422-3. PubMed ID: 14851666
    [No Abstract]   [Full Text] [Related]  

  • 2. Critical evaluation of the fibrin plate method for estimating fibrinolytic enzymes and activators.
    AUERSWALD W; DOLESCHEL W
    Thromb Diath Haemorrh; 1960 Oct; 5():112-20. PubMed ID: 13685088
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the fibrinolytic effect of urine; inhibition of urinary fibrinolysis after subcutaneous injection of hyaluronidase].
    SEELICH F; PANTLITSCHKO M; KAISER E
    Enzymologia; 1953 Apr; 16(1):56-61. PubMed ID: 13068376
    [No Abstract]   [Full Text] [Related]  

  • 4. [Interpretation of postoperative fibrinolysis in pulmonary excision; study of the fibrinolytic activity of blood in excised lungs and in lungs after experimental trauma and collapses].
    TONELLI L; SCALFATI P
    Archivio Chir Torace; 1956; 13(1):165-83. PubMed ID: 13314825
    [No Abstract]   [Full Text] [Related]  

  • 5. An immunological method for demonstrating fibrin degradation products in serum and its use in the diagnosis of fibrinolytic states.
    FERREIRA HC; MURAT LG
    Br J Haematol; 1963 Jul; 9():299-310. PubMed ID: 13944884
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of fluorescein-labeled fibrin for the determination of fibrinolytic activity.
    PAPPENHAGEN AR; KOPPEL JL; OLWIN JH
    J Lab Clin Med; 1962 Jun; 59():1039-46. PubMed ID: 14483756
    [No Abstract]   [Full Text] [Related]  

  • 7. Prolonged activation of fibrinolytic system induced by fibrin nonselective thrombolytic agent can contribute to preventing early reocclusion after coronary thrombolytic therapy.
    Goto S; Kawai Y; Handa S; Takahashi E; Ogawa S; Watanabe K; Hori S; Ikeda Y
    Cardiology; 1993; 82(4):274-9. PubMed ID: 8402754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [THROMBOLYSIS: DIRECT DETERMINATION OF FIBRINOLYTIC SUBSTANCES BY MEANS OF STATIC RETRACTROMETRY].
    SCHULTE W
    Thromb Diath Haemorrh; 1964 Oct; 12():282-94. PubMed ID: 14224639
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fetal fibrinogen. II. Studies on the fibrinolytic resistance of "umbilical vein fibrin"].
    KUENZER W
    Klin Wochenschr; 1962 May; 40():478-81. PubMed ID: 14460280
    [No Abstract]   [Full Text] [Related]  

  • 10. Fibrinolysis. I. Fibrinolytic activity of extracts from non-pathogenic fungi.
    STEFANINI M; MARIN H
    Proc Soc Exp Biol Med; 1958 Nov; 99(2):504-7. PubMed ID: 13601918
    [No Abstract]   [Full Text] [Related]  

  • 11. [FIBRINOLYTIC ACTIVITY OF COMMERCIAL THROMBINS AND THEIR INFLUENCE ON THE ACCURACY OF THE STANDARD FIBRIN PLATE METHOD].
    SCHULTE W
    Thromb Diath Haemorrh; 1965 Jun; 13():561-71. PubMed ID: 14347877
    [No Abstract]   [Full Text] [Related]  

  • 12. LOCALIZATION OF FIBRINOLYTIC ACTIVITY IN MYOCARDIAL INFARCTS IN RATS.
    KWAAN HC; ASTRUP T
    Thromb Diath Haemorrh; 1964 Dec; 12():407-17. PubMed ID: 14254700
    [No Abstract]   [Full Text] [Related]  

  • 13. FIBRIN SUSPENSION ASSAY FOR FIBRINOLYTIC ACTIVITY.
    DYER AE; KADAR D
    Blood; 1964 Jun; 23():729-40. PubMed ID: 14161407
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. II. The significance, mechanism and consequences of defective fibrin polymerization.
    ALKJAERSIG N; FLETCHER AP; SHERRY S
    J Clin Invest; 1962 Apr; 41(4):917-34. PubMed ID: 13860492
    [No Abstract]   [Full Text] [Related]  

  • 15. [THE THROMBOPLASTIC AND FIBRINOLYTIC ACTIVITIES OF RED BLOOD CELLS].
    KUENZER W; HABERHAUSEN D
    Klin Wochenschr; 1964 Feb; 42():165-8. PubMed ID: 14152616
    [No Abstract]   [Full Text] [Related]  

  • 16. Highly potent fibrinolytic serine protease from Streptomyces.
    Uesugi Y; Usuki H; Iwabuchi M; Hatanaka T
    Enzyme Microb Technol; 2011 Jan; 48(1):7-12. PubMed ID: 22112764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disturbed Laminar Blood Flow Causes Impaired Fibrinolysis and Endothelial Fibrin Deposition In Vivo.
    Glise L; Larsson P; Jern S; Borén J; Levin M; Ny T; Fogelstrand P; Bergh N
    Thromb Haemost; 2019 Feb; 119(2):223-233. PubMed ID: 30602198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products.
    FLETCHER AP; ALKJAERSIG N; SHERRY S
    J Clin Invest; 1962 Apr; 41(4):896-916. PubMed ID: 13893560
    [No Abstract]   [Full Text] [Related]  

  • 19. POST MORTEM ACTIVATION OF HUMAN BLOOD FIBRINOLYTIC ENZYME IN SUDDEN AND NATURAL DEATHS.
    HABA K; KUMANO O; MOHRI M; TAKEMARU H; KAWANISHI K; TOBE S; KAMADA T; UENO S
    Acta Med Okayama (1952); 1963; 17():279-88. PubMed ID: 14168972
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. III. Demonstration of abnormal clot structure by electron microscopy.
    BANG NU; FLETCHER AP; ALKJAERSIG N; SHERRY S
    J Clin Invest; 1962 Apr; 41(4):935-48. PubMed ID: 13864646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.